Literature DB >> 9864161

von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver.

R J Kaufman1, A J Dorner, D N Fass.   

Abstract

Factor VIII and von Willebrand factor (vWF) circulate in the plasma as a noncovalent protein complex. Circulating levels of factor VIII are coordinately regulated with circulating levels of vWF in which the ratio is maintained at 1 molecule of factor VIII for 50 to 100 vWF subunits. Infusion of vWF into vWF-deficient animal models and human patients yields a secondary increase in circulating levels of factor VIII. We have studied the mechanism of the secondary rise in factor VIII in a porcine model of vWF deficiency. On infusion of vWF into a vWF-deficient pig there was an approximately fivefold increase in circulating factor VIII activity. Liver biopsies were taken pre- and post-vWF infusion for isolation of total messenger RNA (mRNA). Factor VIII-specific mRNA was measured by an RNAse protection assay. The results showed no difference in the liver-specific factor VIII mRNA on vWF infusion. These results indicate that the secondary rise in factor VIII levels in response to exogenous vWF infusion is not dependent on increased steady-state levels of factor VIII mRNA in the liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864161

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity.

Authors:  Vivek S Purohit; Sathyamangalam V Balasubramanian
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

2.  Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.

Authors:  Junliang Pan; Thanh Theresa Dinh; Anusha Rajaraman; Mike Lee; Alexander Scholz; Cathrin J Czupalla; Helena Kiefel; Li Zhu; Lijun Xia; John Morser; Haiyan Jiang; Laura Santambrogio; Eugene C Butcher
Journal:  Blood       Date:  2016-05-12       Impact factor: 22.113

3.  ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.

Authors:  Kristine S Alexander; Neil A Zakai; Sarah Gillett; Leslie A McClure; Virginia Wadley; Fred Unverzagt; Mary Cushman
Journal:  Neurology       Date:  2014-09-10       Impact factor: 9.910

4.  Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.

Authors:  Anetta Lasek-Bal; Przemysław Puz; Zofia Kazibutowska
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-17       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.